Meta-Analysis
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7384-7393
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7384
Figure 1
Figure 1 Effect of neoadjuvant chemotherapy on overall survival rate. A: Overall survival rate (fixed effects model); B Overall survival rate (random effects model).
Figure 2
Figure 2 Publication bias in the included studies. Funnel plot analysis of potential publication bias. OR: Odds ratio.
Figure 3
Figure 3 Effect of neoadjuvant chemotherapy in progression free survival rate. A: Progression free survival rate (fixed effects model); B Progression free survival rate (random effects model).
Figure 4
Figure 4 Effect of neoadjuvant chemotherapy in tumor down-staging. A: Tumor down-staging rate (fixed effects model); B Tumor down-staging rate (random effects model).
Figure 5
Figure 5 Effect of neoadjuvant chemotherapy in tumor R-0 resection. A: R-0 resection rate (fixed effects model); B: R-0 resection rate (random effects model).
Figure 6
Figure 6 Effect of neoadjuvant chemotherapy in perioperative mortality. A: Perioperative mortality rate (fixed effects model); B: Perioperative mortality rate (random effects model).
Figure 7
Figure 7 Effect of neoadjuvant chemotherapy in postoperative complications. A: Postoperative complications rate (fixed effects model); B: Postoperative complications rate (random effects model).
Figure 8
Figure 8 Subgroup analysis showing different overall survival rates in patients with advanced gastric cancer.